Elevance Health (ELV) Gross Margin (2009 - 2026)

Elevance Health (ELV) has 18 years of Gross Margin data on file, last reported at 86.7% in Q2 2026.

• On a quarterly basis, Gross Margin rose 7563.0% year-over-year to 86.7% in Q2 2026; TTM through Jun 2026 was 35.59%, a 8291.0% decrease from a year earlier, with the FY2025 full-year figure at 25.56%, down 6074.0% from the prior year.
• Gross Margin for Q2 2026 stood at 86.7%, up from 13.18% in the prior quarter.
• Over the last five years, Gross Margin for ELV reached as high as 632.7% in Q4 2024 and fell as low as 75.84% in Q4 2023.
• Historically, Gross Margin has averaged 75.17% across 5 years, with a median of 28.43% in 2023.
• Across the five-year window, Gross Margin jumped 70854 bps in 2024 and sank 60922 bps in 2025, its largest moves.
• Year by year, Gross Margin stood at 78.85% in 2022, then plunged by 196 bps to 75.84% in 2023, then jumped by 934 bps to 632.7% in 2024, then slumped by 96 bps to 23.48% in 2025, then soared by 269 bps to 86.7% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 86.7% in Q2 2026, 13.18% in Q1 2026, and 23.48% in Q4 2025.